11/24/14 14:55 | 11/14/14 | RTRX | Retrophin, Inc. | DE | Health | Drug | Pharmaceutical Preparations | Shkreli Martin | NY | H | Fmr Offi | S.dm | -10,357 | 8.84 | 4 | -1,172 | -40 | 1,765 | D | 310 | 37 | -43 | -34 | -12 | -21 | -29 | -9 | 5 | 22 | 54 | 74 | 265 | 145 |
10/9/14 11:11 | 10/1/14 | RTRX | Retrophin, Inc. | DE | Health | Drug | Pharmaceutical Preparations | Shkreli Martin | NY | DOT | CEO | P | 203 | 8.11 | 6 | 25 | 1 | 2,995 | D | | 62 | -49 | -4 | -22 | -11 | 7 | -4 | -5 | -5 | -4 | 34 | 121 | 83 |
10/9/14 11:11 | 10/1/14 | RTRX | Retrophin, Inc. | DE | Health | Drug | Pharmaceutical Preparations | Shkreli Martin | NY | DOT | CEO | S | -3 | 0.0100 | 6 | -300 | -9 | 2,995 | D | | 62 | -49 | -4 | -22 | -11 | 7 | -4 | -5 | -5 | -4 | 34 | 121 | 83 |
10/2/14 21:30 | 9/30/14 | RTRX | Retrophin, Inc. | DE | Health | Drug | Pharmaceutical Preparations | Shkreli Martin | NY | DOT | CEO | P | 38 | 9.42 | 5 | 4 | 0 | 2,937 | D | | 33 | -63 | -31 | -29 | -33 | -19 | -15 | 10 | 7 | -4 | 27 | 162 | 125 |
9/23/14 10:54 | 9/19/14 | RTRX | Retrophin, Inc. | DE | Health | Drug | Pharmaceutical Preparations | Shkreli Martin | NY | DOT | CEO | P.m | 591 | 11.15 | 4 | 53 | 2 | 2,933 | D | | 47 | -44 | -8 | -15 | -26 | -18 | -7 | 2 | -8 | -11 | 30 | 116 | 112 |
9/18/14 11:28 | 9/17/14 | RTRX | Retrophin, Inc. | DE | Health | Drug | Pharmaceutical Preparations | Shkreli Martin | NY | DOT | CEO | P | 69 | 11.46 | 3 | 6 | 0 | 2,880 | D | | 68 | -37 | 3 | -1 | -15 | -13 | -10 | 3 | -5 | -13 | -3 | 93 | 156 |
9/16/14 19:51 | 9/16/14 | RTRX | Retrophin, Inc. | DE | Health | Drug | Pharmaceutical Preparations | Shkreli Martin | NY | DOT | CEO | P | 80 | 10.69 | 2 | 8 | 0 | 2,874 | D | | 68 | -31 | 7 | 12 | -4 | -12 | -10 | -8 | -15 | -23 | -20 | 19 | 133 |
6/3/14 21:50 | 5/30/14 | RTRX | Retrophin, Inc. | DE | Health | Drug | Pharmaceutical Preparations | Shkreli Martin | NY | DOT | CEO | S | -4,427 | 15.14 | 6 | -292 | -9 | 2,867 | D | | 113 | 106 | -19 | 4 | 18 | 13 | 4 | -12 | -15 | -7 | 2 | -22 | 127 |
4/7/14 10:16 | 4/4/14 | RTRX | Retrophin, Inc. | DE | Health | Drug | Pharmaceutical Preparations | Shkreli Martin | NY | DOT | CEO | P | 157 | 19.64 | 15 | 8 | 0 | 2,983 | D | | 262 | 191 | 127 | 0 | 9 | -7 | -11 | -5 | -19 | -33 | -38 | -43 | 21 |
4/4/14 11:53 | 4/3/14 | RTRX | Retrophin, Inc. | DE | Health | Drug | Pharmaceutical Preparations | Shkreli Martin | NY | DOT | CEO | P | 508 | 22.60 | 14 | 23 | 1 | 2,975 | D | | 310 | 213 | 164 | 8 | 22 | 3 | 0 | -10 | -14 | -35 | -39 | -53 | 11 |
4/3/14 09:34 | 4/2/14 | RTRX | Retrophin, Inc. | DE | Health | Drug | Pharmaceutical Preparations | Shkreli Martin | NY | DOT | CEO | P | 241 | 22.28 | 13 | 11 | 0 | 2,952 | D | | 354 | 259 | 234 | 37 | 32 | 24 | 18 | -10 | -13 | -39 | -47 | -63 | 2 |
3/27/14 10:20 | 3/24/14 | RTRX | Retrophin, Inc. | DE | Health | Drug | Pharmaceutical Preparations | Shkreli Martin | NY | DOT | CEO | P | 70 | 17.61 | 8 | 4 | 0 | 2,941 | D | | 311 | 240 | 194 | 93 | 10 | 18 | 12 | -5 | 14 | -36 | -43 | -47 | 8 |
3/21/14 13:36 | 3/20/14 | RTRX | Retrophin, Inc. | DE | Health | Drug | Pharmaceutical Preparations | Shkreli Martin | NY | DOT | CEO | P | 90 | 17.97 | 7 | 5 | 0 | 2,937 | D | | 244 | 180 | 175 | 88 | 9 | 1 | 10 | -4 | 1 | -28 | -43 | -39 | 16 |
3/20/14 12:24 | 3/19/14 | RTRX | Retrophin, Inc. | DE | Health | Drug | Pharmaceutical Preparations | Shkreli Martin | NY | DOT | CEO | P | 65 | 18.44 | 7 | 4 | 0 | 2,932 | D | | 231 | 165 | 142 | 81 | -6 | -9 | 4 | 7 | 14 | -20 | -38 | -37 | 23 |
3/17/14 16:15 | 3/14/14 | RTRX | Retrophin, Inc. | DE | Health | Drug | Pharmaceutical Preparations | Shkreli Martin | NY | DOT | CEO | P | 69 | 17.36 | 7 | 4 | 0 | 2,929 | D | | 265 | 143 | 127 | 64 | -9 | -7 | -9 | 7 | 5 | -26 | -36 | -27 | -16 |
3/12/14 09:49 | 3/11/14 | RTRX | Retrophin, Inc. | DE | Health | Drug | Pharmaceutical Preparations | Shkreli Martin | NY | DOT | CEO | P | 504 | 19.47 | 9 | 26 | 1 | 2,925 | D | | 323 | 207 | 119 | 73 | 19 | 8 | 1 | -1 | -2 | 7 | -40 | -33 | -20 |
3/11/14 10:45 | 3/10/14 | RTRX | Retrophin, Inc. | DE | Health | Drug | Pharmaceutical Preparations | Shkreli Martin | NY | DOT | CEO | P | 207 | 19.32 | 9 | 11 | 0 | 2,899 | D | | 267 | 230 | 133 | 83 | 27 | 4 | 7 | -4 | -12 | -2 | -43 | -34 | -23 |
3/10/14 10:20 | 3/6/14 | RTRX | Retrophin, Inc. | DE | Health | Drug | Pharmaceutical Preparations | Shkreli Martin | NY | DOT | CEO | P.m | 75 | 18.52 | 9 | 4 | 0 | 2,888 | D | | 340 | 222 | 144 | 85 | 30 | 1 | 5 | 3 | -10 | -7 | -46 | -31 | -22 |
3/6/14 09:32 | 3/5/14 | RTRX | Retrophin, Inc. | DE | Health | Drug | Pharmaceutical Preparations | Shkreli Martin | NY | DOT | CEO | P | 74 | 18.48 | 8 | 4 | 0 | 2,884 | D | | 337 | 209 | 153 | 50 | 74 | -2 | 5 | 1 | 1 | 14 | -37 | -25 | -24 |
3/3/14 10:00 | 2/21/14 | RTRX | Retrophin, Inc. | DE | Health | Drug | Pharmaceutical Preparations | Shkreli Martin | NY | DOT | CEO | P.m | 804 | 18.66 | 8 | 43 | 2 | 2,880 | D | | 302 | 195 | 152 | 47 | 70 | 10 | -7 | 1 | 9 | 20 | -17 | -23 | -20 |
2/25/14 09:00 | 2/21/14 | RTRX | Retrophin, Inc. | DE | Health | Drug | Pharmaceutical Preparations | Shkreli Martin | NY | DOT | CEO | P | 28 | 17.56 | 7 | 2 | 0 | 2,837 | D | | 292 | 192 | 217 | 124 | 93 | 78 | 19 | 0 | -6 | 7 | -28 | -35 | -28 |
2/19/14 10:40 | 2/14/14 | RTRX | Retrophin, Inc. | DE | Health | Drug | Pharmaceutical Preparations | Shkreli Martin | NY | DOT | CEO | P | 51 | 14.60 | 6 | 4 | 0 | 2,836 | D | | 270 | 166 | 160 | 87 | 42 | 52 | 46 | 3 | 22 | 16 | -16 | -23 | -6 |
2/7/14 12:52 | 2/6/14 | RTRX | Retrophin, Inc. | DE | Health | Drug | Pharmaceutical Preparations | Shkreli Martin | NY | DOT | CEO | P | 20 | 9.92 | 2 | 2 | 0 | 2,832 | D | | 185 | 105 | 47 | 38 | -14 | -7 | 4 | 1 | 56 | 93 | 7 | 15 | 29 |
1/15/14 06:01 | 1/14/14 | RTRX | Retrophin, Inc. | DE | Health | Drug | Pharmaceutical Preparations | Shkreli Martin | NY | DOT | CEO | P | 87 | 10.84 | 2 | 8 | 0 | 2,830 | D | | 199 | 101 | 69 | 51 | 58 | 32 | 30 | 6 | 12 | 44 | 5 | -2 | 28 |
1/14/14 19:04 | 9/12/13 | RTRX | Retrophin, Inc. | DE | Health | Drug | Pharmaceutical Preparations | Shkreli Martin | NY | DOT | CEO | P.ad | 25 | 4.50 | 1 | 6 | 0 | 2,669 | D | | 184 | 102 | 76 | 62 | 72 | 42 | 44 | 6 | 13 | -4 | 17 | -3 | 19 |
1/2/14 06:41 | 12/31/13 | RTRX | Retrophin, Inc. | DE | Health | Drug | Pharmaceutical Preparations | Shkreli Martin | NY | DOT | CEO | P.d | 1,050 | 7.00 | 1 | 150 | 6 | 2,816 | D | | 109 | 43 | 8 | 19 | -11 | 4 | 0 | 14 | 13 | 51 | 234 | 78 | 75 |
12/10/13 14:33 | 12/6/13 | RTRX | Retrophin, Inc. | DE | Health | Drug | Pharmaceutical Preparations | Shkreli Martin | NY | DOT | CEO | P.m | 2 | 8.21 | 0 | 0 | 0 | 2,666 | D | | 72 | 25 | 13 | 16 | 37 | 16 | 3 | -3 | -8 | 5 | 132 | 40 | 21 |
12/2/13 15:51 | 11/22/13 | RTRX | Retrophin, Inc. | DE | Health | Drug | Pharmaceutical Preparations | Shkreli Martin | NY | DOT | CEO | P.m | 3 | 6.31 | 0 | 0 | 0 | 2,666 | D | | 248 | 0 | 17 | 6 | -3 | 23 | 7 | 5 | 24 | 0 | 162 | 91 | 44 |
9/16/13 17:11 | 9/12/13 | RTRX | Retrophin, Inc. | OK | Health | Drug | Pharmaceutical Preparations | Shkreli Martin | NY | DOT | CEO | P.d | 50 | 4.50 | 0 | 11 | 0 | 2,671 | D | | | 52 | 24 | 21 | 15 | 13 | 1 | 0 | 6 | -3 | 3 | 148 | 73 |
8/23/13 14:15 | 8/21/13 | RTRX | Retrophin, Inc. | OK | Health | Drug | Pharmaceutical Preparations | Shkreli Martin | NY | DOT | CEO | P.m | 24 | 6.06 | 0 | 4 | 0 | 2,660 | D | | | 34 | 8 | 7 | 9 | 30 | 14 | -2 | -8 | 2 | -8 | 192 | 89 |
3/12/13 13:31 | 3/6/13 | RTRX | Retrophin, Inc. | OK | Financ | AcqCo | Blank Checks | Shkreli Martin | NY | DOT | CEO | P.m | 2 | 4.61 | 0 | 1 | 0 | 2,656 | D | | | | -4 | 15 | 2 | 2 | 3 | -3 | 18 | 30 | 62 | 38 | 323 |
3/6/13 14:21 | 3/4/13 | RTRX | Retrophin, Inc. | OK | Financ | AcqCo | Blank Checks | Shkreli Martin | NY | DOT | CEO | P | 4 | 4.43 | 0 | 1 | 0 | 2,656 | D | | | | 111 | 6 | 21 | -12 | -3 | 3 | 2 | 21 | 75 | 41 | 337 |
2/21/13 14:44 | 2/20/13 | RTRX | Retrophin, Inc. | OK | Financ | AcqCo | Blank Checks | Shkreli Martin | NY | DOT | CEO | P | 5 | 4.16 | 0 | 1 | 0 | 2,655 | D | | | | 109 | 6 | 9 | 24 | 12 | 25 | 11 | 35 | 52 | 27 | 305 |
2/19/13 16:14 | 2/14/13 | RTRX | Desert Gateway, Inc. | OK | Financ | AcqCo | Blank Checks | Shkreli Martin | NY | DOT | CEO | P.d | 360 | 3.00 | 0 | 120 | 5 | 2,654 | D | | | | 109 | 25 | 8 | 17 | 20 | -5 | 7 | 25 | 65 | 34 | 265 |
2/13/13 18:41 | 2/12/13 | RTRX | Desert Gateway, Inc. | OK | Financ | AcqCo | Blank Checks | Shkreli Martin | NY | DOT | CEO | P | 5 | 3.57 | 0 | 1 | 0 | 2,534 | D | | | | 133 | 4 | -29 | -5 | 0 | -9 | 2 | 18 | 119 | 25 | 187 |
12/28/12 12:30 | 12/17/12 | RTRX | Desert Gateway, Inc. | OK | Financ | AcqCo | Blank Checks | Shkreli Martin | NY | DOT | CEO | P.m | 1 | 5.62 | 0 | 0 | 0 | 2,532 | D | | | | | 54 | -34 | -60 | -25 | -7 | 8 | 26 | 69 | 79 | 123 |